CJC1295

CJC1295 is a synthetic growth hormone secretagogue. It specifically belongs to the growth hormone releasing hormone (GHRH) family of drugs. These compounds all mimic the effects of endogenous GHRH, a 44-amino acid hypothalamic peptide hormone that stimulates the release of growth hormone from the pituitary gland. CJC1295 is actually a very long acting GHRH analog. Whereas native GHRH has a half-life measured in minutes, which reduces its practicality as a therapeutic agent, CJC1295 is capable of sustained increases in growth hormone and IGF-1 with as little as once per week administration.

The primary benefit of CJC1295 is an increased level of HGH and IGF-1, that affects nearly every cell in the human body from bone and muscle, lungs, skin and even the central nervous system. They are essential in the regulation and promotion of healing and recovery as well as in the regulation of the metabolism.

Side Effects

Common side effects to CJC1295 include flushing, warmth, dizziness, and transient hypotension following injection. Other common side effects include headache, diarrhea, nausea, and abdominal pain. Many side effects are dose dependent.

High doses are normally responsible for water or fluid retention and can be reduced by dose alterations. Some users may also find they experience a numbing or tingling sensation in their hands or feet during the course of use.

Headaches can also be a side effect of CJC1295, which is most commonly due to the use of the peptide and drops in blood sugar. Diet adjustments may need to be made during use.

Nausea and diarrhea are also possible yet very unlikely side effects of CJC1295.

Administration

CJC1295 is a water base injectable peptide hormone. Users will apply bacteriostatic water to the dry CJC-1295 powder in order to mix and draw out the desired dose.

Injections can be performed intramuscularly or subcutaneously.

500-1000mcg per week is the standard dosing range with 500mcg two times per week being optimal for most.